Two authors equally contributed to this work.
Attenuated pain responses in mice lacking CaV3.2 T-type channels
Article first published online: 29 AUG 2006
2006 Blackwell Publishing Ltd
Genes, Brain and Behavior
Volume 6, Issue 5, pages 425–431, July 2007
How to Cite
Choi, S., Na, H. S., Kim, J., Lee, J., Lee, S., Kim, D., Park, J., Chen, C.-C., Campbell, K. P. and Shin, H.-S. (2007), Attenuated pain responses in mice lacking CaV3.2 T-type channels. Genes, Brain and Behavior, 6: 425–431. doi: 10.1111/j.1601-183X.2006.00268.x
- Issue published online: 8 SEP 2006
- Article first published online: 29 AUG 2006
- Received 6 December 2005, revised 15 July 2006, accepted for publication 22 July 2006
- Chemical pain;
- mechanical pain;
- neuropathic pain;
- spinal nerve ligation (SNL);
- thermal pain;
- tonic inflammatory pain
Although T-type Ca2+ channels are implicated in nociception, the function of specific subtypes has not been well defined. Here, we compared pain susceptibility in mice lacking CaV3.2 subtype of T-type Ca2+ channels (CaV3.2−/−) with wild-type littermates in various behavioral models of pain to explore the roles of CaV3.2 in the processing of noxious stimuli in vivo. In acute mechanical, thermal and chemical pain tests, CaV3.2−/− mice showed decreased pain responses compared to wild-type mice. CaV3.2−/− mice also displayed attenuated pain responses to tonic noxious stimuli such as intraperitoneal injections of irritant agents and intradermal injections of formalin. In spinal nerve ligation-induced neuropathic pain, however, behavioral responses of CaV3.2−/− mice were not different from those of wild-type mice. The present study reveals that the CaV3.2 subtype of T-type Ca2+ channels are important in the peripheral processing of noxious signals, regardless of modality, duration or affected tissue type.
Pain, such as acute somatic, tonic inflammatory and visceral pain, is often found to be insensitive to conventional remedies. Therefore, a better understanding of the molecular mechanisms of pain is needed to assist in the discovery of novel therapeutics. Changes in the expression and the excitability of Ca2+ channels has been suggested to play a pivotal role in the generation of pain (Bourinet & Zamponi 2005; Heinke et al. 2004; Newton et al. 2001). In particular, low voltage-activated T-type Ca2+ channels, originally identified in peripheral sensory neurons of the dorsal root ganglion (DRG), have been thought to modulate pain processing because they play a crucial role in controlling neuronal excitability of the DRG (Carbone & Lux 1984; White et al. 1989). Based on studies of the effects of mibefradil, a preferential T-type Ca2+ channel blocker, and redox modulation of T-channels, Todorovic et al. suggested a peripheral pronociceptive role for T-type Ca2+ channels in pain transmission (Todorovic et al. 2001, 2002, 2004). In addition, blocking of spinal T-type Ca2+ channels with ethosuximide depressed neuronal responses in the spinal dorsal horn (Matthews & Dickenson 2001). T-type Ca2+ channels have also been shown to be involved in the development of long-term potentiation (LTP) at synapses between nociceptive afferents and dorsal horn neurons of the spinal cord (Heinke et al. 2004; Ikeda et al. 2003). Although T-type Ca2+ channels are known to be important in pain perception, the understanding of their function is still at an early stage.
Three subtypes of T-type channel have been cloned, namely, CaV3.1 (α1G), CaV3.2 (α1H) and CaV3.3 (α1I) (Cribbs et al. 1998, 2000; Gomora et al. 2002; Lee et al. 1999; Zhuang et al. 2000). Gene expression analysis demonstrated that the CaV3.2 subtype is predominantly found at sites essential for pain transmission, such as medium- and small-sized sensory neurons of the DRG and the superficial laminae of the dorsal horn (Talley et al. 1999). This expression pattern for CaV3.2 indicates that this subtype may be important for peripheral pain perception. Although Bourinet et al. recently showed reduced mechanical nociception in healthy or mononeuropathic rats following antisense-mediated knockdown of CaV3.2 (Bourinet et al. 2005), further exploration of the role of this channel in various pain modalities is still needed to fully validating it as a target for analgesic drug development. In the present study, we therefore investigated the roles of the CaV3.2 subtype in the perception of various noxious signals as well as mechanical noxious stimuli. Our results revealed that the CaV3.2 subtype of T-type Ca2+ channels has a pronociceptive role not only in mechanical nociception but also in thermal, chemical and tonic inflammatory pain but that it may not be critical for the development of neuropathic pain.
Materials and methods
Mice lacking the CaV3.2 subtype of T-type Ca2+ channels were generated by gene targeting (Chen et al. 2003), and CaV3.2 null mutations were maintained in 129/sv or C57BL/6J mice, which have different genetic backgrounds. Heterozygotic mice obtained from chimeras were backcrossed into each genetic background more than six times (≥N6). To evaluate the gene knockout effect on general behaviors and nociceptive responses, hybrid F1 CaV3.2−/− and wild-type littermate control mice were generated by mating heterozygotes from the two genetic backgrounds (129/sv and C57BL/6J). Mice were given free access to food and water and maintained under a 12-h light/12-h dark cycle, with the light cycle beginning at 0600 h. The genotype was confirmed by polymerase chain reaction analysis of tail biopsies. Animal care and all behavior tests including pain tests were conducted under the ethical guidelines of the Institutional Animal Care and Use Committee of the Korea Institute of Science and Technology and the International Association for the Study of Pain. In all pain tests, different groups of CaV3.2−/− mice and their wild-type littermates were used except in the spinal nerve ligation (SNL)-induced neuropathic pain test.
Behavioral assays of various pains
Tail clip test
A tail clip test was used to assess sensitivity to noxious mechanical stimuli. An alligator clip (exerting a force of 250g; Fine Science Tools Inc., North Vancouver, Canada) was applied to the tail 1 cm from the tip. The latency to licking/biting of the clip or trembling of the clipped tail within 1 cm from the nose was measured.
Tail flick test
To assess tail heat sensitivity, a tail flick test was performed using a plantar test device (7370 plantar test; Ugo Basile, Italy) at high-intensity infrared radiation (infrared intensity of 50) with a maximum cutoff time of 15 seconds. Before the test, mice were habituated for 1 h in transparent restrainers with a glass floor. To obtain the mean latency of tail flicks, five trials of heat stimulation were applied with a 10-min interval using a radiant heat source.
Hot plate test
A hot plate test was conducted to assess hind paw heat sensitivity. Mice were habituated for 1 h in a transparent testing box with a metal floor (15 × 15 × 25 cm). A mouse was then placed in a box that was preheated to 52.5°C in a thermoregulated water bath, and the latency to hind paw licking or jumping was assessed.
To assess acute pain responses to a chemical, 1-μg capsaicin (10 μl) was injected subcutaneously into the dorsal region of the hind paw. The time spent licking or biting the injected paw was measured over 5 min.
To assess chemical-induced acute and tonic pain, 2% paraformaldehyde (10 μl) was injected subcutaneously into the dorsal region of the hind paw. The cumulative time that an animal spent licking or biting the injected paw was measured every 5 min for 1 h.
Visceral pain test
To assess visceral pain, mice were injected intraperitoneally with 0.6% acetic acid (5 ml/kg body weight), which evokes an inflammatory reaction-induced persistent pain, or 12 mg/ml MgSO4 (10 ml/kg body weight), which induces an immediate visceral pain response independent of inflammation. The number of abdominal writhes such as stretches and contractions was counted within 20 min or 5 min of injection of acetic acid or MgSO4, respectively.
Behavioral assay of neuropathic pain by SNL
Surgical procedure for SNL
Neuropathic surgery was performed under gaseous anesthesia with a mixture of enflurane (2% for induction and 0.5% for maintenance) and oxygen. The L5 spinal nerve was ligated according to the procedure of Kim and Chung (1992). Briefly, following surgical preparation and exposure of the dorsal vertebral column from L4 to S2, the L6 vertebral transverse process was removed and the L5 spinal nerve was tightly ligated with a 6-0 silk thread under a dissecting microscope. Complete hemostasis was confirmed, and the wound was sutured closed. These animals were used in a series of SNL-induced neuropathic pain tests in the following order: (1) spontaneous pain test, (2) mechanical allodynia and (3) thermal hyperalgesia at low-intensity (IR 30) and high-intensity (IR 60) infrared radiation.
Spontaneous pain test
To measure the spontaneous pain response in the hind paw following L5 SNL, we used a modification of the formalin test rating system (Dubuisson & Dennis 1977). Following surgery, a mouse was placed in an open-topped transparent plastic cylinder (6 cm diameter × 16 cm height) and allowed to move freely for 20 min before being observed. During the subsequent 3-min observation period, the cumulative time during which the mouse held its foot off the floor was measured. Foot lifts during locomotion or body repositioning were not included in the measurement. The average score for two trials was calculated.
Mechanical allodynia (von Frey test)
To assess hind paw mechanical sensitivity, the withdrawal threshold of the hind paw was measured using the up–down method (Chaplan et al. 1994). For each test, the animal was placed under a transparent plastic chamber (9.5 × 5.5 × 5 cm) on a metal mesh floor. The 50% withdrawal threshold was determined using a set of von Frey filaments (0.02, 0.07, 0.16, 0.4, 1, 2, 4 and 6 g; Stoelting, Wood Dale, IL, USA). A brisk foot lift upon filament application was regarded as a withdrawal response. Mice first received a stimulus using the 0.4-g filament, and, if there was a withdrawal response, the next smallest filament was used. If there was no response, the next largest filament was used.
Thermal hyperalgesia (paw withdrawal test)
To assess hind paw heat sensitivity, Hargreaves’ test was conducted using a plantar test device (7371 plantar test; Ugo Basile, Italy) (Hargreaves et al. 1988). Animals were allowed to freely move within an open-topped transparent plastic cylinder (6 cm diameter × 16 cm height) on a glass floor 20 min before the test. A mobile radiant heat source was then placed under the glass floor and focused onto the hind paw. Paw withdrawal latencies were measured with a cutoff time of 15 seconds. Two different intensities were employed: low (IR 30) and high (IR 60). The heat stimulation was repeated three times with a 10-min interval to obtain the mean latency of paw withdrawal.
General behavioral assays
A cubic box was made of polyacrylic plastic plates without a ceiling (40 × 40 × 40 cm), the arena of which was divided into 16 equal squares. After being placed in a holding cage for 10 min, each mouse was transferred to the center of the arena and the activity of animals was recorded with a video camera. Horizontal activities (number of squares crossed) and vertical activities (number of rearing) were assessed for 1 h.
A rotarod apparatus (Rota-rod LE 8200; Letica Scientific Instrument, Spain) was used to explore coordinated locomotor function in mice. Mice were placed on a 3-cm diameter rod that slowly accelerated from 0 rpm to constant speeds of rotation. The speed of the rotating rod in each test session was set at 5–35 rpm, with a 5-rpm increment. After a 1-min training session on the rod, each mouse was tested in a single session at a specific speed for 1 min. The latency to falling from the rotating rod at each speed was recorded by the rotarod timer.
Light/dark activity test
The test box (45 cm × 25 cm × 25 cm) for the light/dark activity test was composed of two compartments: one compartment (2/3 of the space) was illuminated by bright light (illumination >500 lux), the other compartment was painted black, not illuminated and covered by a black lid. The compartments were connected by an opening (7.5 cm × 7.5 cm) located in the center of a partition at the floor level. Each mouse was placed in the center of the dark compartment facing the opening, and the activity of the animals was recorded by a video camera fixed 30 cm above the floor. The latency to movement into the light compartment and the time spent in the light compartment were measured during 10 min.
sas version 8.02 (SAS, Inc., Cary, NC, USA) was used for statistical analysis, and Sigma plot (SPSS, Inc., Chicago, IL, USA) was used for creating graphs. The paw-licking times following formalin injections were analyzed by two-way analysis of variance (anova). Tukey‘s honestly significant difference method was used for post hoc comparisons. A Mann–Whitney rank sum test, which is a nonparametric analog to the t-test, was used to investigate all behavioral responses induced by neuropathic pain, spontaneous pain, mechanical allodynia and thermal hyperalgesia. All other comparisons between two genotypes were performed by Student’s t-test.
Pronociceptive role of CaV3.2 in mechanical, thermal and chemical cutaneous pain
We examined the behavioral responses in CaV3.2−/− mice to mechanical, thermal or chemical stimuli to determine the role of CaV3.2 in acute pain. In a tail clip test to assess the susceptibility to mechanical pain, CaV3.2−/− mice displayed a dramatic increase in the latency to tail licking/biting or flicking reactions (Fig. 1a; P < 0.001 by Student‘s t-test). In tail flick (Fig. 1b) and hot plate tests (Fig. 1c), CaV3.2−/− mice showed a significantly prolonged latency to heat-induced behavior (P < 0.01 and P < 0.001, respectively, by Student’s t-test). We also examined the response of mice to chemical stimulation using capsaicin. We found that Cav3.2−/− mice showed a dramatic reduction in paw-licking response to capsaicin compared to wild-type littermates (Fig. 1d; P < 0.001 by Student‘s t-test). Collectively, these results indicate that, compared to wild-type mice, CaV3.2−/− mice have a reduced sensitivity to acute pain induced by mechanical, thermal and chemical means.
Noxious chemical stimulation, for example, by intradermal injection of formalin into the hind paw, induces a biphasic pain behavioral response: an early-phase paw-licking response due to direct stimulation of peripheral nociceptors, followed by late-phase responses due to inflammation-induced persistent input of pain signals at the supraspinal level (Abbadie et al. 1997; Taylor et al. 1995). We administered an intradermal injection of formalin into the hind paws of CaV3.2−/− and wild-type mice and recorded their biphasic licking responses. CaV3.2−/− mice exhibited a markedly shorter duration of paw licking (i.e., reduced pain response) in both phases compared to wild-type littermates (Fig. 2 line graph, F1,31= 15.25 and P= 0.0005 by two-way anova with Tukey’s post hoc test; Fig. 2 bar graph, P < 0.05 by Student‘s t-test).
Reduced abdominal writhing in CaV3.2-deficient mice in response to chemical visceral pain
To confirm the role of CaV3.2 channels as enhancers of pain signals, we performed abdominal writhing (stretching or contracting) tests in CaV3.2−/− mice. Writhing was induced by injecting mice with acetic acid, which evokes persistent inflammatory reaction-induced pain, or by intraperitoneal injection with MgSO4, which induces an immediate visceral pain response independent of inflammation. Compared to wild-type controls, CaV3.2−/− mice showed fewer incidents of writhing in response to both types of visceral pain (Fig. 3a,b; P < 0.01 and P < 0.05, respectively, by Student’s t-test).
Normal neuropathic pain responses in CaV3.2−/− mice
To define the roles of CaV3.2 in neuropathic pain, CaV3.2−/− mice and their wild-type littermates underwent L5 SNL, and a variety of behavioral responses relevant to neuropathic pain were evaluated. We found that both genotypes of mice developed similar levels of spontaneous pain, mechanical allodynia and thermal hyperalgesia following L5 SNL. CaV3.2−/− mice did not differ from wild-type mice in the overall development of neuropathic pain (Fig. 4), except for a modest decrease in thermal hyperalgesia at high-intensity (IR 60) irradiation on day 21 after L5 SNL (Fig. 4d; P < 0.05 by Mann–Whitney rank sum test).
Normal general behaviors in CaV3.2-deficient mice
We next examined the general behavior of the mutant mice. In an open-field box test, the horizontal and vertical activities of CaV3.2−/− mice were indistinguishable from those of wild-type mice (Fig. 5a,b). In a rotarod test, we did not observe any difference between mutant and wild-type mice in their duration on the rotating rotarod at various speeds (Fig. 5c). In the light/dark transition test to measure the level of anxiety, the latency to move into the light compartment and the time spent in the light compartment did not differ between CaV3.2−/− mice and wild-type littermates (Fig. 5d). These results indicate that the deletion of CaV3.2 does not cause significant abnormalities in motor-associated and emotion-related functions that could have biased interpretation of the results from the various pain tests.
Using mice lacking CaV3.2 T-type Ca2+ channels, we have shown that the CaV3.2 subtype plays a pronociceptive role in acute and tonic cutaneous pain caused by a variety of noxious stimuli as well as in chemical visceral pain. Previous studies have shown that the viability, fertility and ratios of specific tissues to total body weight are normal in CaV3.2−/− mice, although they have abnormal coronary function and are slightly smaller than littermate controls (Chen et al. 2003). There were no significant differences in heart rate between wild-type mice and mutant mice in the current study. In addition, deletion of CaV3.2 did not result in abnormalities of locomotion, motor coordination and skill, or anxiety, which indicate normal behavioral performance of the mutant mice. Thus, the observed reductions in behavioral pain responses in CaV3.2−/− mice evoked by various noxious stimuli or stimulation of somatic or visceral tissues appears to be due to an alteration in nociceptive processing rather than other defects.
Previous studies showed that CaV3.2−/− mice lost almost all T-type Ca2+ currents in DRG neurons, which are involved in the transmission of pain signals from the periphery, and did not show any significant change in other Ca2+ currents (Chen et al. 2003). In the present study, we found that CaV3.2−/− mice exhibit hypoalgesic responses to acute somatic, visceral and tonic inflammatory pain. Thus, the hypoalgesic responses of CaV3.2−/− mice suggest that the T-type Ca2+ currents supported by CaV3.2 play a critical role in pain perception. The present findings are consistent with recent results obtained using intrathecal delivery of antisense oligonucleotides directed against CaV3.2, which showed that this channel participates in the response to noxious mechanical stimuli (Bourinet et al. 2005). The abundant expression of CaV3.2 in small- and medium-sized DRG neurons (Talley et al. 1999) appears to be a possible cause of the hypoalgesic response in the mutant mice. Our previous study revealed a thalamic antinociceptive function of the CaV3.1 subtype; specifically, CaV3.1−/− mice showed increased visceral pain but no significant difference in peripheral pain (Kim et al. 2003). In addition, in agreement with the visceral pain results, following intradermal injection of formalin into the hind paw of CaV3.1−/− mice, there was no difference in the licking duration of the early phase, which is elicited by direct stimulation of peripheral nociceptors (Le Bars et al. 2001), whereas the licking duration of the late phase was increased (data not shown).
In spinal cord, T-type Ca2+ channels mediate sensitivity to pain by controlling synaptic efficiency between primary afferent nerve fibers and intrinsic spinal cord neurons, which was suggested to be the mechanism for neuropathic (Heinke et al. 2004; Ikeda et al. 2003). Recently, Bourinet et al. demonstrated that selective silencing of CaV3.2 elevates the paw withdrawal threshold for tactile stimuli after chronic constriction injury (CCI) suggesting the involvement of CaV3.2 in this model of neuropathic pain (Bourinet et al. 2005). These findings appear to be in conflict with our present data showing no significant role for CaV3.2 channels in neuropathic pain induced by L5 SNL. This discrepancy could be due to the differences in the types of pain models used, namely CCI and SNL. Although these two animal models show behavioral signs of neuropathic pain, there is a considerable difference between them both in the magnitude of each pain component and the effect of sympathectomy (Kim et al. 1997). It is also conceivable that developmental compensatory mechanisms might have eliminated the need for CaV3.2 in CaV3.2−/− mice. On the other hand, several lines of evidence support the idea that CaV3.2 T-type channels are not essential for induction of central sensitization following peripheral nerve injury. Although persistent tonic afferent drive of small- and medium-sized DRG neurons resulting from peripheral nerve injury are known to be important for the generation of neuropathic pain (Zimmermann 2001), T-type calcium currents in medium-sized DRG neurons, probably supported by Cav3.2, are unaffected or downregulated following peripheral nerve injury (Andre et al. 2003; Baccei & Kocsis 2000; Hogan et al. 2000; McCallum et al. 2003). Thus, T-currents mediated by Cav3.2 may be unrelated to the neuropathic pain caused by peripheral nerve injury.
In the present study, exploration of various pain behaviors in CaV3.2−/− mice was conducted to validate CaV3.2 as a molecular target for analgesic drugs. Although antisense-mediated knockdown studies by Bourinet et al. have already shown that this subtype plays an important role in mechanical nociception (Bourinet et al. 2005), our results revealed that CaV3.2 also participates in the perception of various noxious signals as well as mechanical noxious stimuli. Our results with respect to neuropathic pain, however, seem to contradict those of Bourinet et al. (Bourinet et al. 2005). Further studies are required to determine the extent to which CaV3.2 T-type channels contribute to the development of neuropathic pain and the role each subtype plays in the modulation of LTP between primary sensory neurons and neurons of the spinal dorsal horn. In conclusion, our results suggest that the CaV3.2 subtype of T-type Ca2+ channels plays a pronociceptive role in not only mechanical nociception but also thermal, chemical and tonic inflammatory pain.
- 1997) Differential contribution of the two phases of the formalin test to the pattern of c-fos expression in the rat spinal cord: studies with remifentanil and lidocaine. Pain 69, 101–110. , , & . (
- 2003) Axotomy-induced expression of calcium-activated chloride current in subpopulations of mouse dorsal root ganglion neurons. J Neurophysiol 90, 3764–3773. , , , , , , & . (
- 2000) Voltage-gated calcium currents in axotomized adult rat cutaneous afferent neurons. J Neurophysiol 83, 2227–2238. & . (
- 2005) Voltage gated calcium channels as targets for analgesics. Curr Top Med Chem 5, 539–546. & . (
- 2005) Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception. Embo J 24, 315–324. , , , , , , , , , & . (
- 1984) A low voltage-activated, fully inactivating Ca channel in vertebrate sensory neurones. Nature 310, 501–502. & . (
- 1994) Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia. J Pharmacol Exp Ther 269, 1117–1123. , & . (
- 2003) Abnormal coronary function in mice deficient in alpha1H T-type Ca2+ channels. Science 302, 1416–1418. , , , , , , , , , , , & . (
- 1998) Cloning and characterization of alpha1H from human heart, a member of the T-type Ca2+ channel gene family. Circ Res 83, 103–109. , , , , , , , , , & . (
- 2000) Molecular cloning and functional expression of Ca(v)3.1c, a T-type calcium channel from human brain. FEBS Lett 466, 54–58. , , , & . (
- 1977) The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 4, 161–174. & . (
- 2002) Cloning and expression of the human T-type channel Ca(v)3.3: insights into prepulse facilitation. Biophys J 83, 229–241. , , , & . (
- 1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32, 77–88. , , , & . (
- 2004) Pre- and postsynaptic contributions of voltage-dependent Ca2+ channels to nociceptive transmission in rat spinal lamina I neurons. Eur J Neurosci 19, 103–111. , & . (
- 2000) Painful neuropathy decreases membrane calcium current in mammalian primary afferent neurons. Pain 86, 43–53. , , , , , & . (
- 2003) Synaptic plasticity in spinal lamina I projection neurons that mediate hyperalgesia. Science 299, 1237–1240. , , & . (
- 1997) Comparison of three rodent neuropathic pain models. Exp Brain Res 113, 200–206. , & . (
- 2003) Thalamic control of visceral nociception mediated by T-type Ca2+ channels. Science 302, 117–119. , , , , , & . (
- 1992) An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50, 355–363. & . (
- 2001) Animal models of nociception. Pharmacol Rev 53, 597–652. , & . (
- 1999) Cloning and expression of a novel member of the low voltage-activated T-type calcium channel family. J Neurosci 19, 1912–1921. , , , , , , & . (
- 2001) Effects of ethosuximide, a T-type Ca(2+) channel blocker, on dorsal horn neuronal responses in rats. Eur J Pharmacol 415, 141–149. & . (
- 2003) Loss of T-type calcium current in sensory neurons of rats with neuropathic pain. Anesthesiology 98, 209–216. , , , & . (
- 2001) Dorsal root ganglion neurons show increased expression of the calcium channel alpha2delta-1 subunit following partial sciatic nerve injury. Brain Res Mol Brain Res 95, 1–8. , , , & . (
- 1999) Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels. J Neurosci 19, 1895–1911. , , , , & . (
- 1995) Persistent cardiovascular and behavioral nociceptive responses to subcutaneous formalin require peripheral nerve input. J Neurosci 15, 7575–7584. , & . (
- 2001) Redox modulation of T-type calcium channels in rat peripheral nociceptors. Neuron 31, 75–85. , , , , , , & . (
- 2002) Mechanical and thermal antinociception in rats following systemic administration of mibefradil, a T-type calcium channel blocker. Brain Res 951, 336–340. , & . (
- 2004) Redox modulation of peripheral T-type Ca2+ channels in vivo: alteration of nerve injury-induced thermal hyperalgesia. Pain 109, 328–339. , & . (
- 1989) Transient low-threshold Ca2+ current triggers burst firing through an afterdepolarizing potential in an adult mammalian neuron. Proc Natl Acad Sci USA 86, 6802–6806. , & . (
- 2000) Cloning of a T-type Ca2+ channel isoform in insulin-secreting cells. Diabetes 49, 59–64. , , , , , , , & . (
- 2001) Pathobiology of neuropathic pain. Eur J Pharmacol 429, 23–37. . (
We thank Joonoh Park and Jaeseong Park for mice care, and Hannah Seong for the analysis of pain behaviors. This work was supported by the Chemoinformatics Program and the Center-of-Excellence program of the Korea Institute of Science and Technology, and in part by a grant (M103KV010009 03K220100910) from the Brain Research Center of the 21st Century Frontier Research Program funded by the Ministry of Science and Technology of the Republic of Korea. K.P.C. is an investigator of the Howard Hughes Medical Institute.